Role of farnesoid X receptor and bile acids in alcoholic liver disease

被引:1
|
作者
Sharon Manley [1 ]
Wenxing Ding [1 ]
机构
[1] Department of Pharmacology, Toxicology and Therapeutics, the University of Kansas Medical Center
基金
美国国家卫生研究院;
关键词
Farnesoid X receptor; Bile acids; Autophagy; Alcoholic liver disease; FoxO3;
D O I
暂无
中图分类号
R96 [药理学];
学科分类号
100602 ; 100706 ;
摘要
Alcoholic liver disease(ALD) is one of the major causes of liver morbidity and mortality worldwide. Chronic alcohol consumption leads to development of liver pathogenesis encompassing steatosis, inflammation, fibrosis, cirrhosis, and in extreme cases, hepatocellular carcinoma. Moreover,ALD may also associate with cholestasis. Emerging evidence now suggests that farnesoid X receptor(FXR) and bile acids also play important roles in ALD. In this review, we discuss the effects of alcohol consumption on FXR, bile acids and gut microbiome as well as their impacts on ALD. Moreover, we summarize the findings on FXR, Fox O3a(forkhead box-containing protein class O3a) and PPARα(peroxisome proliferator-activated receptor alpha) in regulation of autophagy-related gene transcription program and liver injury in response to alcohol exposure.
引用
收藏
页码:158 / 167
页数:10
相关论文
共 50 条
  • [21] Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease
    Xi, Yingfei
    Li, Hongshan
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 121
  • [22] The Status of Bile Acids and Farnesoid X Receptor in Brain and Liver of Rats with Thioacetamide-Induced Acute Liver Failure
    Czarnecka, Anna Maria
    Milewski, Krzysztof
    Albrecht, Jan
    Zielinska, Magdalena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (20) : 1 - 12
  • [23] Nutraceutical targeting of the bile acid receptor, farnesoid X receptor, for intestinal disease
    Fallon, Ciara M.
    Quach, Andrew
    Lajczak-McGinley, Natalia
    Smyth, Jessica S.
    Curley, Caitriona E.
    Hazel, Karl
    Boland, Karen
    O'Toole, Aoibhlinn
    Barrett, Kim E.
    Sheridan, Helen
    Keely, Stephen J.
    FASEB JOURNAL, 2022, 36
  • [24] Neutraceutical Targeting of the Bile Acid Receptor, Farnesoid X Receptor, for Intestinal Disease
    Fallon, Ciara
    Edupuganti, Omprakash
    Lajczak-McGinley, Natalia
    Sheridan, Helen
    Keely, Stephen
    FASEB JOURNAL, 2020, 34
  • [25] Farnesoid X receptor activation by bile acids suppresses lipid peroxidation and ferroptosis
    Juliane Tschuck
    Lea Theilacker
    Ina Rothenaigner
    Stefanie A. I. Weiß
    Banu Akdogan
    Van Thanh Lam
    Constanze Müller
    Roman Graf
    Stefanie Brandner
    Christian Pütz
    Tamara Rieder
    Philippe Schmitt-Kopplin
    Michelle Vincendeau
    Hans Zischka
    Kenji Schorpp
    Kamyar Hadian
    Nature Communications, 14
  • [26] Bile Acids and Farnesoid X Receptor: Novel Target for the Treatment of Diabetic Cardiomyopathy
    Li, Chao
    Li, Yunlun
    Gai, Zhibo
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2019, 20 (10) : 976 - 983
  • [27] Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor
    Yang, Fan
    Huang, Xiongfei
    Yi, Tangsheng
    Yen, Yun
    Moore, David D.
    Huang, Wendong
    CANCER RESEARCH, 2007, 67 (03) : 863 - 867
  • [28] FARNESOID X RECEPTOR: ACTING THROUGH BILE ACIDS TO TREAT METABOLIC DISORDERS
    Zhang, Y.
    DRUGS OF THE FUTURE, 2010, 35 (08) : 635 - 641
  • [29] Farnesoid X receptor activation by bile acids suppresses lipid peroxidation and ferroptosis
    Tschuck, Juliane
    Theilacker, Lea
    Rothenaigner, Ina
    Weiss, Stefanie A. I.
    Akdogan, Banu
    Van Thanh Lam
    Mueller, Constanze
    Graf, Roman
    Brandner, Stefanie
    Puetz, Christian
    Rieder, Tamara
    Schmitt-Kopplin, Philippe
    Vincendeau, Michelle
    Zischka, Hans
    Schorpp, Kenji
    Hadian, Kamyar
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [30] Discovery of farnesoid X receptor and its role in bile acid metabolism
    Chiang, John Y. L.
    Ferrell, Jessica M.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2022, 548